Skip to main content
Earnings Labs
MaxCyte, Inc. logo

MaxCyte, Inc. (MXCT)

NASDAQ·Healthcare·Biotechnology

$1.11

+3.27%

Mkt Cap $112.48M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (3 analysts)

$6.00

Range $6.00$6.00

Implied Upside

+443.0%

Consensus $6.00 vs current $1.11